9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine
C42H24N4O2 — CID 168785048
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine
9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine (PubChem CID 168785048) has the molecular formula C42H24N4O2 and a molecular weight of 616.68 g/mol. Its IUPAC name is 9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine.
Molecular Properties
| Compound Name | 9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine |
|---|---|
| PubChem CID | 168785048 |
| Molecular Formula | C42H24N4O2 |
| Molecular Weight | 616.68 g/mol |
| Exact Mass | 616.19 |
| IUPAC Name | 9-[3-(4-dibenzofuran-1-yl-6-phenyl-1,3,5-triazin-2-yl)naphthalen-1-yl]-[1]benzofuro[3,2-c]pyridine |
| SMILES | c1ccc(-c2nc(-c3cc(-c4cccc5oc6ccncc6c45)c4ccccc4c3)nc(-c3cccc4oc5ccccc5c34)n2)cc1 |
| InChI | InChI=1S/C42H24N4O2/c1-2-10-25(11-3-1)40-44-41(46-42(45-40)31-16-9-19-37-39(31)30-14-6-7-17-34(30)47-37)27-22-26-12-4-5-13-28(26)32(23-27)29-15-8-18-36-38(29)33-24-43-21-20-35(33)48-36/h1-24H |
| InChIKey | FXHJUEJEMOYIBD-UHFFFAOYSA-N |
| XLogP | 10.89 |
| TPSA | 77.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 616.68 |
| LogP ≤ 5 | 10.89 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168785048 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.